Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical Trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical Trial

Published:2018-07 Issue:1 Volume:198 Page:51-57
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Kunisaki Ken M.¹²^ORCID,Dransfield Mark T.³⁴,Anderson Julie A.⁵,Brook Robert D.⁶,Calverley Peter M. A.⁷,Celli Bartolome R.⁸,Crim Courtney⁹,Hartley Benjamin F.¹⁰,Martinez Fernando J.¹¹,Newby David E.¹²,Pragman Alexa A.¹²,Vestbo Jørgen¹³,Yates Julie C.⁹,Niewoehner Dennis E.¹²

Affiliation:

1. Minneapolis Veterans Affairs Health Care System, Minneapolis, Minnesota

2. University of Minnesota, Minneapolis, Minnesota

3. Lung Health Center, University of Alabama at Birmingham, Birmingham, Alabama

4. Birmingham Veterans Affairs Medical Center, Birmingham, Alabama

5. GlaxoSmithKline, Stockley Park, United Kingdom

6. University of Michigan, Ann Arbor, Michigan

7. University of Liverpool, Liverpool, United Kingdom

8. Brigham and Women’s Hospital, Boston, Massachusetts

9. GlaxoSmithKline, Research Triangle Park, North Carolina

10. Veramed Ltd., Twickenham, United Kingdom

11. Weill Cornell Medical College of Cornell University, New York, New York

12. University of Edinburgh, Edinburgh, United Kingdom; and

13. University of Manchester, Manchester, United Kingdom

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Link

https://www.atsjournals.org/doi/pdf/10.1164/rccm.201711-2239OC

Reference26 articles.

1. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016

2. Why Are Patients With Chronic Obstructive Pulmonary Disease at Increased Risk of Cardiovascular Diseases?

3. Cardiovascular Comorbidity in COPD

4. A Lower Level of Forced Expiratory Volume in 1 Second Is a Risk Factor for All-Cause and Cardiovascular Mortality in a Japanese Population: The Takahata Study

5. Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype

Cited by 215 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is ‘Cardiopulmonary’ the New ‘Cardiometabolic’? Making a Case for Systems Change in COPD;Pulmonary Therapy;2024-09-09

2. Influence of heart failure (HF) comorbidity in chronic obstructive pulmonary disease (COPD) and isolated forms of HF and COPD on cardiovascular function during hospitalization;Respiratory Medicine;2024-09

3. Cardiovascular events after exacerbations of chronic obstructive pulmonary disease: Results from the EXAcerbations of COPD and their OutcomeS in CardioVascular diseases study in Italy;European Journal of Internal Medicine;2024-09

4. Riesgo de eventos cardiovasculares graves tras agudizaciones de la EPOC: resultados del estudio EXACOS-CV en España;Revista Española de Cardiología;2024-08

5. Prognostic potential of neutrophil-to-lymphocyte ratio, platelet to lymphocyte ratio, and monocyte to lymphocyte ratio in acute myocardial infarction patients combined with chronic obstructive pulmonary disease;Frontiers in Cardiovascular Medicine;2024-07-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3